Reubi JC, Maecke HR (2008) Peptide-based probes for cancer imaging. J Nucl Med 49(11):1735–1738

Article  CAS  PubMed  Google Scholar 

Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J et al (2021) Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer 146:56–73

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ezziddin S, Adler L, Sabet A, Pöppel TD, Grabellus F, Yüce A et al (2014) Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system. J Nucl Med 55(8):1260–1266

Article  CAS  PubMed  Google Scholar 

Yu R, Wachsman A (2017) Imaging of neuroendocrine tumors: indications, interpretations, limits, and pitfalls. Endocrinol Metab Clin North Am 46(3):795–814

Article  CAS  PubMed  Google Scholar 

Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T et al (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 112(11):2447–2455

Article  PubMed  Google Scholar 

Zhou Y, Li L, Wang H, Huang HX, Cao D, Ke NW et al (2024) Heterogeneous Uptake of 68 Ga-DOTATATE and 18 F-FDG in initial diagnosed neuroendocrine tumors patients : which patients are suitable for dual-tracer PET imaging? Clin Nucl Med 49(6):516–520

Article  PubMed  Google Scholar 

Paiella S, Landoni L, Tebaldi S, Zuffante M, Salgarello M, Cingarlini S et al (2022) Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1–G2 nonfunctioning pancreatic neuroendocrine tumors: a single-center retrospective evaluation of 124 nonmetastatic resected cases. Neuroendocrinology 112(2):143–152

Article  CAS  PubMed  Google Scholar 

Hayes AR, Furtado O’Mahony L, Quigley AM, Gnanasegaran G, Caplin ME, Navalkissoor S et al (2022) The combined interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in metastatic gastroenteropancreatic neuroendocrine tumors: a classification system with prognostic impact. Clin Nucl Med 47(1):26–35

Article  PubMed  Google Scholar 

Magi L, Prosperi D, Lamberti G, Marasco M, Ambrosini V, Rinzivillo M et al (2022) Role of [(18)F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors. Endocrine 76(2):484–490

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binderup T, Knigge U, Johnbeck CB, Loft A, Berthelsen AK, Oturai P et al (2021) (18)F-FDG PET is superior to WHO grading as a prognostic tool in neuroendocrine neoplasms and useful in guiding PRRT: a prospective 10-year follow-up study. J Nucl Med 62(6):808–815

Article  PubMed  Google Scholar 

Metser U, Nunez JE, Chan D, Kulanthaivelu R, Murad V, Santiago AT et al (2024) Dual somatostatin receptor/(18)F-FDG PET/CT imaging in patients with well-differentiated, grade 2 and 3 gastroenteropancreatic neuroendocrine tumors. J Nucl Med 65(10):1591–1596

Article  CAS  PubMed  Google Scholar 

Liu G, Mao W, Yu H, Hu Y, Gu J, Shi H (2023) One-stop [(18)F]FDG and [(68)Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study. Eur J Nucl Med Mol Imaging 50(8):2271–2281

Article  CAS  PubMed  Google Scholar 

Zheng Z, He Y, Mao W, Yu H, Wu H, Yang R et al (2025) Exploration the feasibility and additional value of [(18)F]FDG/[(68)Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [(68)Ga]Ga-FAPI-04. Eur J Nucl Med Mol Imaging 52(2):638–647

Article  PubMed  Google Scholar 

Beiderwellen KJ, Poeppel TD, Hartung-Knemeyer V, Buchbender C, Kuehl H, Bockisch A et al (2013) Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results. Invest Radiol 48(5):273–279

Article  CAS  PubMed  Google Scholar 

Flechsig P, Zechmann CM, Schreiweis J, Kratochwil C, Rath D, Schwartz LH et al (2015) Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET. Eur J Radiol 84(8):1593–1600

Article  PubMed  Google Scholar 

Ding W, Yu J, Zheng C, Fu P, Huang Q, Feng DD et al (2022) Machine learning-based noninvasive quantification of single-imaging session dual-tracer (18)F-FDG and (68)Ga-DOTATATE dynamic PET-CT in oncology. IEEE Trans Med Imaging 41(2):347–359

Article  PubMed  Google Scholar